Announcement • May 26
2cureX AB (publ), Annual General Meeting, Jun 25, 2026 2cureX AB (publ), Annual General Meeting, Jun 25, 2026, at 10:00 W. Europe Standard Time. Location: premises of forvis mazars, nordenskioldsgatan 11a, se-211 19 malmo, sweden, malmo Sweden New Risk • Dec 30
New major risk - Share price stability The company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of Swedish stocks, typically moving 14% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risks Latest financial reports are more than 1 year old (reported June 2024 fiscal period end). Share price has been highly volatile over the past 3 months (14% average weekly change). Shareholders have been substantially diluted in the past year (43% increase in shares outstanding). Market cap is less than US$10m (kr12.9m market cap, or US$1.40m). New Risk • Aug 24
New major risk - Financial data availability The company's latest financial reports are more than a year old. Last reported fiscal period ended June 2024. This is considered a major risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. In the worst case scenario, it may be facing other major going concern issues jeopardizing its viability as a listed company. Currently, the following risks have been identified for the company: Major Risks Latest financial reports are more than 1 year old (reported June 2024 fiscal period end). Share price has been highly volatile over the past 3 months (24% average weekly change). Revenue has declined by 50% over the past year. Shareholders have been substantially diluted in the past year (43% increase in shares outstanding). Revenue is less than US$1m (kr2.0m revenue, or US$208k). Market cap is less than US$10m (kr77.3m market cap, or US$8.14m). 
